Page last updated: 2024-08-21

arsenic trioxide and menaquinone 6

arsenic trioxide has been researched along with menaquinone 6 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Kang, K; Qu, H; Ren, L; Tong, D; Zhang, Y	1

Other Studies

1 other study(ies) available for arsenic trioxide and menaquinone 6

Article	Year
The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway. Die Pharmazie, 2013, Volume: 68, Issue:10 Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspase 3; Caspase 9; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; HL-60 Cells; Humans; Indicators and Reagents; Mitogen-Activated Protein Kinases; Oxides; Reactive Oxygen Species; Signal Transduction; Vitamin K 2	2013

Article

Year

The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway.

Die Pharmazie, 2013, Volume: 68, Issue:10

Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspase 3; Caspase 9; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; HL-60 Cells; Humans; Indicators and Reagents; Mitogen-Activated Protein Kinases; Oxides; Reactive Oxygen Species; Signal Transduction; Vitamin K 2

2013